The effect of financial incentives on top of behavioral support on quit rates in tobacco smoking employees: study protocol of a cluster-randomized trial

BMC Public Health

Volumn 16, Issue 1, 2016, Pages 1-9

  Van Den Brand, F A ^a   Nagelhout, G E ^a   Winkens, B ^a   Evers, S M A A ^a,b   Kotz, D ^a,c   Chavannes, N H ^d   Van Schayck, C P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Employees; Incentives; Intervention; Reward; Smoking cessation; Tobacco

Indexed keywords

ADOLESCENT; ADULT; CONTROLLED STUDY; COUNSELING; ECONOMICS; FEMALE; GROUP PROCESS; HEALTH PROMOTION; HUMAN; MALE; METHODOLOGY; MOTIVATION; OCCUPATIONAL HEALTH SERVICE; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; REWARD; SMOKING; SMOKING CESSATION;

ADOLESCENT; ADULT; COUNSELING; FEMALE; GROUP PROCESSES; HEALTH PROMOTION; HUMANS; MALE; MOTIVATION; OCCUPATIONAL HEALTH SERVICES; RESEARCH DESIGN; REWARD; SMOKING; SMOKING CESSATION;

EID: 84992035191     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-3729-y     Document Type: Article

References (49)

1. U.S. Department of Health and Human Services. The health consequences of smoking-50 years of progress. a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-Century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341-50.
3. Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med. 2015;48(3):326-33.
4. Berman M, Crane R, Seiber E, Munur M. Estimating the cost of a smoking employee. Tob Control. 2014;23(5):428-33.
5. Halpern MT, Shikiar R, Rentz AM, Khan ZM. Impact of smoking status on workplace absenteeism and productivity. Tob Control. 2001;10(3):233-8.
6. CBS. Gezondheid en zorg in cijfers (Health and care in numbers). The Hague: OBT bv; 2007.
7. Weng SF, Ali S, Leonardi-Bee J. Smoking and absence from work: systematic review and meta-analysis of occupational studies. Addiction. 2013;108(2):307-19.
8. Eriksen MP, Gottlieb NH. A review of the health impact of smoking control at the workplace. Am J Health Promot. 1998;13(2):83-104.
9. Osinubi OY, Slade J. Tobacco in the workplace. Occup Med. 2002;17(1):137-58.
10. O'Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89:103-24.
11. Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298(20):2415-7.
12. Giles EL, Robalino S, McColl E, Sniehotta FF, Adams J. The Effectiveness of financial incentives for health behaviour change: systematic review and meta-analysis. PLoS ONE. 2014;9(3):e90347.
13. Haff N, Patel MS, Lim R, Zhu J, Troxel AB, Asch DA, et al. The Role of behavioral economic incentive design and demographic characteristics in financial incentive-based approaches to changing health behaviors: a meta-analysis. Am J Health Promot. 2015;29(5):314-23.
14. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database of Systematic Reviews. 2015; doi:10.1002/14651858.CD004307.pub5
15. Tappin D, Bauld L, Purves D, Boyd K, Sinclair L, MacAskill S, et al. Financial incentives for smoking cessation in pregnancy: randomised controlled trial. BMJ. 2015;350:h134.
16. Businelle MS, Kendzor DE, Kesh A, Cuate EL, Poonawalla IB, Reitzel LR, et al. Small financial incentives increase smoking cessation in homeless smokers: a pilot study. Addict Behav. 2014;39(3):717-20.
17. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, et al. Smoking cessation in methadone maintenance. Addiction. 2002;97(10):1317-28.
18. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009;360(7):699-709.
19. Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews. Addiction. 2013;108(10):1711-21.
20. Giskes K, Kunst AE, Ariza C, Benach J, Borrell C, Helmert U, et al. Applying an equity lens to tobacco-control policies and their uptake in six Western-European countries. J Public Health Policy. 2007;28(2):261-80.
21. Huisman M, Kunst AE, Mackenbach JP. Inequalities in the prevalence of smoking in the European Union: comparing education and income. Prev Med. 2005;40(6):756-64.
22. Kaper J, Wagena EJ, Willemsen MC, Van Schayck CP. Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction. 2005;100(7):1012-20.
23. Reda AA, Kotz D, Evers SM, van Schayck CP. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Libr. 2012;13(6):CD00430.
24. Boyd KA, Briggs AH, Bauld L, Sinclair L, Tappin D. Are financial incentives cost-effective to support smoking cessation during pregnancy? Addiction. 2015;111(2):360-70. doi:10.1111/add.13160.
25. Verdurmen J, Monshouwer K, Van Laar M, Van Bon-Martens M. Factsheet continu onderzoek rookgewoonten 2013. Utrecht: Trimbos-instituut; 2013.
26. Nagelhout GE, de Korte-de Boer D, Kunst AE, van der Meer RM, de Vries H, van Gelder BM, et al. Trends in socioeconomic inequalities in smoking prevalence, consumption, initiation, and cessation between 2001 and 2008 in the Netherlands. Findings from a national population survey. BMC Public Health. 2012;12(1):1-9.
27. Strand BH, Tverdal A. Can cardiovascular risk factors and lifestyle explain the educational inequalities in mortality from ischaemic heart disease and from other heart diseases? 26 year follow up of 50 000 Norwegian men and women. J Epidemiol Community Health. 2004;58(8):705-9.
28. Stringhini S, Sabia S, Shipley M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010;303(12):1159-66.
29. West RPLJ. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3):299-303.
30. Janjigian YY, McDonnell K, Kris MG, Shen R, Sima CS, Bach PB, et al. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer. 2010;116(3):670-5.
31. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend. 1994;34(3):211-6.
32. Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, et al. What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health. 2010;25(10):1229-45.
33. Schouten HJ. Adaptive biased urn randomization in small strata when blinding is impossible. Biometrics. 1995;51(4):1529-35.
34. Efron B. Forcing a sequential experiment to be balanced. Biometrika. 1971;58(3):403-17.
35. Little RJ, Rubin DB. Statistical analysis with missing data. Hoboken NJ: Wiley; 2014.
36. Noben C, Evers S, Nieuwenhuijsen K, Ketelaar S, Gärtner F, Sluiter J, et al. Protecting and promoting mental health of nurses in the hospital setting: is it cost-effective from an employer's perspective? Int J Occup Med Environ Health. 2015;28(5):891-900.
37. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health policy. 1990;16(3):199-208.
38. Versteegh MM, Vermeulen KM, Evers SM, de Wit GA, Prenger R, Stolk EA. Dutch Tariff for the Five-Level Version of EQ-5D. Value Health. 2016;19(4):343-52.
39. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015.
40. Thorn J, Coast J, Cohen D, Hollingworth W, Knapp M, Noble S, et al. Resource-use measurement based on patient recall: issues and challenges for economic evaluation. Appl Health Econ Health Policy. 2013;11(3):155-61.
41. Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Roijen LH-v. The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015;18(6):753-8.
42. Bouwmans C, Hakkaart-van Roijen L, Koopmanschap M, Krol M, Severens H, Brouwer W. Medical cost questionnaire (iMCQ). Rotterdam: iMTA, Erasmus Universiteit Rotterdam; 2013.
43. Dirum. Database of instruments for resource use management. 2016. www.dirum.org.
44. Tan SS, Bouwmans CAM, Rutten FFH, Hakkaart-van RL. Update of the Dutch manual for costing in economic evaluations. Int J Technol Assess Health Care. 2012;28(02):152-8.
45. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Econ. 1997;6(4):327-40.
46. Cahill K, Lancaster T. Workplace interventions for smoking cessation. Cochrane Database Syst Rev. 2014;26(2):CD003440. doi:10.1002/14651858.CD003440.pub4.
47. Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci. 2012;1248(1):107-23.
48. Reid JL, Hammond D, Boudreau C, Fong GT, Siahpush M. Socioeconomic disparities in quit intentions, quit attempts, and smoking abstinence among smokers in four western countries: findings from the international tobacco control four country survey. Nic tob res. 2010;12 Suppl 1:S20-33. doi:10.1093/ntr/ntq051.
49. Kotz D, West R. Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control. 2009;18(1):43-6.